| Mrs Melissa Darline Vaughan, | |
|
5015 Vance Dr, Anchorage, AK 99508-5652 | |
| (804) 986-6557 | |
| Not Available |
| Full Name | Mrs Melissa Darline Vaughan |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 5015 Vance Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477985968 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 0002066669 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Melissa Darline Vaughan, 5015 Vance Dr, Anchorage, AK 99508-5652 Ph: (804) 986-6557 | Mrs Melissa Darline Vaughan, 5015 Vance Dr, Anchorage, AK 99508-5652 Ph: (804) 986-6557 |
News Archive
A new special issue of SLAS Discovery reflects examples of the recent groundswell of creative new applications for high-throughput flow cytometry in drug discovery.
Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced three new group purchasing agreements with the Premier healthcare alliance.
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today provided an update on its Phase III program with pimavanserin for Parkinson's disease psychosis (PDP), which is being pursued in collaboration with Biovail Laboratories International SRL ("Biovail"), a subsidiary of Biovail Corporation.
A new molecular pathway involving the gene ZNF365 has been identified and abnormalities in that pathway may predict worse outcomes for patients with breast cancer, according to data published in Cancer Discovery, a journal of the American Association for Cancer Research.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced the completion of its initial public offering of six million shares of common stock at a price of $7.00 per share. The net proceeds of the offering to Anthera, after deducting underwriting discounts and commissions and estimated offering expenses payable by Anthera, were approximately $36.7 million.
› Verified 3 days ago
Ms. Dessie Natillia Cooper, RN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 711 H St Ste 100, Anchorage, AK 99501 Phone: 907-770-0862 | |
Cynthia Kelly, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 670 W Fireweed Ln Ste 160, Anchorage, AK 99503 Phone: 907-770-0862 | |
Eteva Tautu, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6916 Windsor Pl, Anchorage, AK 99502 Phone: 907-885-7624 | |
Nicholas Morley, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 121 W Fireweed Ln Ste 105, Anchorage, AK 99503 Phone: 907-865-9653 Fax: 907-865-9124 | |
Ms. Susie Ann Edwards, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-1729 | |
Stephanie Louise Melendez, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 670 W Fireweed Ln Ste 160, Anchorage, AK 99503 Phone: 907-770-0862 | |
Naomi Caskey, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 670 W Fireweed Ln Ste 160, Anchorage, AK 99503 Phone: 907-770-0862 |